Immunization of mice with peptide constructs, consisting of a determinant recognized by T cytotoxic cells colinearly linked to a determinant recognized by T helper cells (TD,-TD 1 ?
INTRODUCTION

Cytotoxic
T lymphocytes (CTL) play an important role in the control of viral infections (Yap et al., 1978; Zinkemagel et al., 1979 ) and tnmour cell growth (Kast et al., 1989; Greenberg, 1991) . For these reasons, the understanding of how CTL are induced in viva is of paramount importance both for vaccine design and cancer therapy.
CTL are usually induced following infection with a virus. Thus, cellular enzymes from infected cells process viral proteins into peptides. Some of these peptides, following association with MHC class I molecules are presented at the surface of the infected cell, which after recognition by a specific T-cell receptor leads to CTL activation (Townsend et al., 1989) . Immunization with inactivated virus or viral proteins does not usually induce CTL (Moore et al., 1988) . This failure is probably due to lack of internalization of the antigen in the cytoplasm of the APC, where endogenous MHC class I processing takes place (Gething et al., 1978; Bangham et al., 1985; Townsend et al., 1986) . Since presentation of peptides linked to class I molecules is an essential step for CTL induction, several groups have developed different immunization strategies to achieve CTL induction in viva using peptides Submitted August 11, 1994 , accepted November 4, 1994 (*) Corresponding author emulsified in Freund's adjuvants (Aichele et al., 1990; Schulz et al., 1991; Fayole et al., 1991; Gao et al., 1991; Hart et al., 1991; Kast et al, 1991) , Iscoms (Takahashi et al., 1990b) , Qss (Shirai et al., 1994) , peptides encapsulated in liposomes (Watari et al., 1987) , protein digests or synthetic peptide constructs in the absence of adjuvants (Ishioka et al., 1987; Carbone et al., 1989; Lasarte et al., 1992) .
Besides the need for internalization of the antigen in the cell to gain access to the class I processing pathway, it has been reported that the helper activity (IL2 production) mediated by CD4+ cells is required to generate CTL in viva (Keene et al., 1982; Leist et al., 1987 Leist et al., , 1989 . This suggests that induction of CTL by a peptide requires that both TD, and TDc moieties are contained in the peptide. Thus, Fayole et al. (1991) and Gao et al. (1991) have found that, after depleting mice of CD4+ cells in viva, no CTL activity could be induced by immunization with peptides. However, in other studies using live virus (Buller et al., 1987; Moskophidis et al., 1987; Ahmed et al., 1988; Mizuochi et al., 1989; Allan et al, 1990) or synthetic peptides (Vasilakos et al., 1993) , in viva depletion of CD4+ cells did not significantly decrease CTL induction. These results suggested that there might be two pathways for CTL induction, one dependent on and another independent of CD4+ T cells (Fayole et al, 1991) .
We provide experimental evidence that CTL can be induced in viva following immunization of mice with peptide construct of the type TDc-TD, in the absence of adjuvant. Moreover, this induction was achieved in non-depleted as well as CD4+-cell-depleted BALB/c mice. In the latter case, CTL induction took place simultaneously with the activation of CD8+ T helper cells, which are specific for a TD, contained within the sequence of RIQRGPGRAFVTIGK, the region from the hypervariable V3 loop from HIV1 that also encompasses the TDc moiety used in the present study. These experiments show that CTL 
Peptide synthesis
Peptides were synthesized by the solid phase method of Merrifield (1963) using the Fmoc altemative (Atherton et al., 1989) . The synthesis was done manually and the ninhydrin test (Kaiser et al., 1970) was used to monitor every step. Couplings were repeated if necessary until a negative ninhydrin test was attained. Peptides were purified by high-performance liquid chromatography on a reverse-phase Cl8 column.
Mice
Female BALBlc and B 10A mice, 4-6 weeks old, were purchased from Panlab (Barcelona, Spain).
Induction of CTL
Groups of three female mice 4-weeks old were immunized three times at days 0, 7 and 14 by i.p. injection of 100 pg of peptide construct dissolved in 0.5 ml of RPMI-1640 medium. At day 21, mice were killed and spleen cells removed and homogenized. Cells were harvested and cultured in vitro in the presence of 5 pg/ml of RIQRGPGRAFVTIGK peptide as described by Isbioka et al. (1987) . Cytolytic activity was measured 5 days after initial culture. The assays were done in triplicate.
Anti-CD4 and anti-CDS monoclonal antibodies
The L3T4 (CD4)-specific rat anti-mouse hybridoma GKl-5 and the CD8-specific rat anti-mouse hybridoma H35.17.2 were used to obtain anti-CD4 and anti-CD8 antibodies. Ascitic fluid was obtained from nude mice pristane-primed and injected with lo6 hybridoma cells. Antibodies were prepared by preciprestricted) previously incubated with 5 pg/ml of relitation with ammonium sulphate and dialysed against evant peptide were used. The assays were done in phosphate buffered saline. The protein concentration triplicate ; the spontaneous release was in all cases was assessed by measurement of the OD at 280 nm. below 20% of total release.
Depletion of CD4+ and CDS+ cells in viva RESULTS Mice were depleted of CD4+ or CDS+ cells by i.p. injection of 300 pg of anti-CD4 or anti-CD8 antibodies, respectively, on days -1, 0, 1, 6, 7, 8, 13, 14 and 15 (Fayole et al., 1991) . The efficiency of the depletion was assessed by flow cytometry on day 21.
Induction
of CTL in BALB/c mice using synthetic peptide constructs IL2 production assay Spleen cells were plated at 1 x lo6 cells per well in a final volume of 200 pl of culture medium in the presence or absence of different dilutions of peptide. Supernatants (50 p.1) were removed 24 h later and IL2 content was measured using a CTL.L bioassay as already described (Lai et al., 1987) .
Cytotoxic activity CTL activity was measured using the conventional cytotoxicity assay (Ishioka et al., 1987) . Target P815 cells (H-2d-restricted) or EL-4 (H-2b-We previously reported (Lasarte et al., 1992 ) that a CTL response could be induced in viva by immunization with the peptide construct RIQRGPGRAFVTIGKKQIINMWQEVG-KAMYA, hereafter referred to as RZQ-KQI, containing a TDc (in italics) and a TD, (KQI) from HIV1 gp160 (Takahashi et al, 1988; Cease et al., 1987) . To expand these results we carried out similar immunization experiments with another peptide construct RIQRGPGRAFVTIGKFI-SEAIIHVLHSR (RZQ-FIS) containing the same TDc but a different TD, (FE, residues 106-l 18 from sperm whale myoglobin (Cease et al., 1986) ). Tables I and II show that peptides RZQ- CTL activity is expressed as % of specific lysis of P815 target cells. IL2 production is expressed as incorporation of 3 H-thymidine in cpm by CTL.L cells (see "Materials and Methods"). This production was measured in the absence or in the presence of 100 pg/ml of anti-CD4 or anti-CD8 antibodies during in virro restimulations with the peptides shown. FIS and RZQ-KQI were able to induce a CTL response against P8 15 target cells preincubated with RZQ. By contrast, free RZQ was unable to induce this response (table III) . Induced CTL presented the surface phenotype CD4-CD8+ as assessed by flow cytometry and by cytotoxic assays in the presence of anti-CD4 or anti-CD8 antibodies plus complement.
Induced CTL were able to lyse P8 15 preincubated with RIQ, but unable to lyse EL-4 cells, showing that they were H-2d-restricted (data not shown).
CTL induction following depletion of CD4+ or CDS+ cells in BALB/c mice
To study the role of CD4+ and CD8+ cells in CTL induction following immunization with RZQ-FIS and RI&-KQI, mice were depleted of CD4+ or CD8+ cells by i.p. injection of anti-CD4 or anti-CD8 antibodies, respectively, as described in "Materials and Methods". At day 21, mice were killed and the spleen cells removed and homogenized.
Analysis of an aliquot of these cells by flow cytometry showed that depletion of CD4+ or CD8+ cells was, in all cases, at least 95 % (data not shown). Following in vitro restimulation of the remaining spleen cells, under the conditions specified in "Materials and Methods", CTL activity was measured. Tables I and II show that, both in RI&-FIS and RZQ-KQI immunized mice which had been depleted of CD4+ cells, CTL activity against P815 target cells incubated with RZQ was not lost, in contrast with the complete abrogation of activity observed in mice depleted of CD8+ cells.
Effect of anti-IL2
receptor antibodies on CTL activity during in vitro restimulation
In order to assess whether CTL induction was IL2-dependent during restimulations, the IL2 receptor was blocked by adding anti-IL2 receptor antibodies. Figure 1 shows that following the addition of these antibodies to spleen cells from mice immunized with RI&-FIS, CTL induction was blocked, proving that the presence of IL2 is 
Effect of antXD4+
or anti-CDS+ addition on CTL activity during in vitro restimulation of cells from non-depleted immunized mice
To study the effect of CD4+ and CD8+ cells during in vitro restimulation of spleen cells from RZQ-KQI immunized BALB/c mice (nondepleted of CD4+ or CD8+ cells), we added anti-CD4 or anti-CD8 antibodies (100 l.tg/ml, final concentration, of the corresponding antibody) to the in vitro restimulation medium. Table IV shows that both anti-CD4+ and anti-CD8+ antibodies abrogated CTL activity. (table I) . This production was substantially blocked after adding anti-CD4 antibodies in vitro and, to a lesser extent, following the addition of anti-CD8 antibodies. It is interesting to note that IL2 production was mainly associated with RZQ-FIS, and that free RZQ and free FIS were much less active.
In the group of non-depleted mice immunized with RI&-KQI (table II) , it can be seen that restimulation with RZQ-KQI or with free KQI induced IL2 production, which was only twice that attained following restimulation without peptide. Mice immunized with RZQ, depleted or nondepleted of CD4+ cells, were unable to induce IL2 production ( (table II) , showed a high level of IL2 production in the presence of RZQ peptide. This induction could be blocked almost completely by anti-CD8 antibodies, when RZQ-KQI or RZQ was used in the in vitro restimulations.
Mice depleted of CD8+ cells in vivo and immunized
with RZQ-FIS (table I) induced IL2 production mainly when restimulated with RZQ-FIS. This induction was substantially decreased after adding anti-CD4 antibodies during in vitro It has been reported that RZQ is a TD, for CD4+ helper lymphocytes of BALB/c mice (Takahashi et al., 1990a) . However, RZQ is also recognized as TD, by CD8+ lymphocytes (tables I and II). In order to confirm the association of this TD, activity with MHC class I (H-2d) restriction, we immunized non-depleted and CD4+-celldepleted BlOA mice (IAk, with RI&-FIS.
These mice share with BALB/c the class I restriction, but differ in their class II restriction. The CTL response as well as the IL2 production in the presence of the different pep-tides was studied. Table V shows that RZQ-FIS induced a significant cytotoxic response only in mice depleted of CD4 cells. IL2 production was also stronger in this group of mice and was mainly due to RZQ. This result confirms that the TD, character of RZQ is associated with CD8+ helper cells, and suggests that it is linked to MHC class I molecules.
DISCUSSION
In addition to internalization of the antigen in the cell in order to gain access to the class I processing pathway, activation of a helper response leading to the production of lymphokines is also essential for proliferation and maturation of CTLs (Keene et al., 1982; Leist et al., 1987 Leist et al., , 1989 .
As was found for two synthetic peptides from LCMV and influenza virus (Fayole er aZ., 1991; Gao et al., 1991) , and as suggested by us for the peptide construct RI&-KQI from HIV 1 gp120 (Lasarte et al., 1992) , induction of a CTL response with these synthetic peptides requires coactivation of a CD4 + helper response. Moreover, the recent work of Shirai et al. (1994) with a similar peptide construct containing RZQ and KQI administered in QS21 saponine adjuvant has confirmed that help from CD4+ lymphocytes induced by the peptide construct is required.
The results of IL2 production reported in tables I and II for non-depleted mice are essentially in agreement with the findings discussed above. Indeed, IL2 production by spleen cells from normal BALBlc mice immunized with RZQ-FIS or RZQ-KQI is dramatically decreased by adding anti-CD4 antibodies during in vitro restimulation.
Moreover, in vitro addition of antiILZreceptor antibodies to spleen cells blocks the restimulation of CTL activity ( fig. 1 ). This restimulation is also blocked by the addition of anti-CD4 as well as by anti-CD8 antibodies (table IV). All these observations suggest that CD4+ cells are required to provide T-cell help to CD8+ cytotoxic T cells. However, in some viral models, it has been observed that in viva depletion of CD4+ cells does not abrogate cytotoxic activity (Buller et al., 1987; Moskophidis et al., 1987; Ahmed et al., 1988; Mizuochi et al., 1989; Allan et al., 1990) . Also, it has been shown that CTL induction after a viral infection can be achieved in the absence of CD4+ cells when CD8+ cells produce the necessary lymphokines to support this induction (Mizuochi et al., 1989) . To explain this apparent discrepancy concerning the role of CD4+ cells in CTL induction, it has been suggested that two different pathways of CTL induction may exist: one dependent on and another independent of CD4+-T-cell help (Fayole et al., 1991) .
To study in more detail the role of different cell populations in CTL induction using synthetic peptides, we analysed the effect of in viva CD4+ or CD8+ depletion. These experiments showed Berzofsky (1991) , Lasarte et al. (1992) and Shirai et al. (1994) . We believe that this might be related to poor internalization of RZQ in the cells, thereby preventing their processing via the MHC class I pathway.
Although the efficiency of in vivo CD4+ depletion was greater than 95% (as measured by flow cytometry; data not shown), it could be argued that IL2 production linked to RZQ in CD4+-depleted mice immunized with RIQ-FIS or RZQ-KQI may have been due to the remaining CD4+ cells. To show that IL2 production induced by RlQ was linked to class I molecules rather than to class II molecules, we immunized BlOA mice (IAk, H-2d) that share with BALB/c (IAd, H-2d) only the class I molecules. Thus, CD4+-depleted BlOA mice immunized with RI&-FIS elicited helper and cytotoxic T-cell responses linked to RZQ (table V), showing that these responses are associated with H-2d class I molecules. It is not clear why CD4+ depletion is required for induction of detectable specific lysis in BIOA mice. However, a tentative explanation might be the following:
as shown in table V, immunization of normal BlOA mice with RZQ-FIS did not elicit T-cell help from either CD4+ or CD8+ cells. Thus, as expected, no CTL induction could take place due to the absence of this help. However, since T-cell help from CD8+ cells was elicited after depletion of CD4+ cells, this led to a concomitant induction of CTL. As opposed to BlOA mice, non-depleted BALB/c mice immunized with RZQ-FYI.5 were able to elicit T-cell help from CD4+ cells, and consequently CTL. However, both in BlOA and BALB/c mice, the pathway of CTL induction linked to help from CDS+ cells takes place only after depletion of CD4+ cells (tables I, II and V). A possible interpretation of this result might be that CD4+ cells sequester the antigen, favouring the CD4+-cell-dependent pathway. Another alternative interpretation is that CD4+ cells might exert a suppressor effect on CD8+ cells.
Under normal conditions (non-depleted mice), the induction of CTL seems to take place via the help from CD4+ cells. Indeed, as shown in table IV, the CTL activity induced in vivo in nondepleted mice can be abrogated by the addition of anti-CD4 antibodies during in vitro restimulation. This result is in agreement with that reported by Takahashi et al. (1990a) on CTL induction using recombinant vaccinia virus expressing HIV 1 gp120.
The appearance of AIDS in HIV-infected patients occurs when the cytotoxic activity and the CD4+ count are low (Gruters et aZ., 1991) . However, the cytotoxic activity seems to remain unchanged for a long period of time, while the CD4+ count decreases progressively (RowlandJones and McMichael, 1993) . It is tempting to postulate that the cytotoxic pathway independent of CD4+ helper cells that we found in CD4+-depleted mice might also be induced at this stage in HIV-infected patients. This might compensate over time for the loss of CD4+ T-cell help over a certain period of time. Moreover, as shown by Mizuochi et al. (1989) for the case of vaccinia virus infection, the activation of CTL via the CD8+ T helper pathway decreases progressively with increasing time. Based on the observation made by Moskophidis et al. (1993) for LCMV infection, showing that the disappearance of CTL activity is due to clonal deletion by exhaustion associated with high viral levels, it could be postulated that the hypothetical CD4+-independent cytotoxic activity in AIDS might vanish due to this clonal deletion. However, if the CD4+-independent pathway for CTL activation has not been induced in HIV-infected patients with a low CD4+ count, immunization of patients with peptide constructs like RZQ-KQI or RZQ-FIS at this stage, might offer some hope of keeping HIV at bay, thus delaying the appearance of AIDS.
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